Med24
metabolic-therapy 28. 10. 2026 • 2 min read • The Journal of biological chemistry (PubMed)

Dysfunction of three CD36 variants is due to impaired glycosylation and trafficking.

CD36 deficiency is characterized by the loss of CD36 due to genetic mutations. Clinical studies have associated CD36 deficiency with hyperlipidemia, insulin resistance, and cardiomyopathy. However, the structural and functional effects of human CD36 variants remain poorly understood. P90S is a causative mutation of...

MASH-riskin tunnistaminen: Tutkimus Ruotsista

CD36 deficiency results from genetic mutations leading to a loss of CD36. Clinical observations link this deficiency with hyperlipidemia, insulin resistance, and cardiomyopathy.

Variant Characterization

Three variants, P90S, E123K, and S127L, are frequently found together and are associated with variable phenotypes. These variants are located in a common structural region of CD36.

HEK293 Cell Studies

In a study utilizing HEK293 cells, the three variants demonstrated impaired binding and uptake of oxidized low-density lipoprotein (oxLDL). This impairment correlated with decreased expression levels and reduced half-lives of the receptors. Altered glycosylation processes were observed in the variants.

Sponsored content

Experiments indicated that inhibiting proteasomal or lysosomal pathways did not restore the stability of the variants. The reduced receptor abundance was not due to a single degradation pathway. The variants exhibited diminished membrane accumulation without preferential localization to specific intracellular compartments.

These findings offer insight into the regulation of human CD36 expression, maturation, and trafficking. The study highlights the functional consequences of genetic variation related to CD36.

Original Scientific Source
The Journal of biological chemistry (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement